Who has invested in ViaLase?

Venture Investors Health Fund, Arboretum Ventures, Falcon Vision, KKR are named among the investors backing ViaLase.

ViaLase Funding: $40M Raised, Series C (2024)

ViaLase funding overview

ViaLase is based in Irvine, California. ViaLase has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in April 2024. The round record for ViaLase runs through 2024; nothing later has been disclosed. Investors on record include Venture Investors Health Fund, Arboretum Ventures, Falcon Vision, KKR. 4 distinct backers are named across the disclosed rounds.

ViaLase at a glance

Total raised: $40M
Latest round: Series C
Latest round date: April 2024
Headquarters: Irvine, California
Notable investors: Venture Investors Health Fund, Arboretum Ventures, Falcon Vision, KKR

Frequently asked about ViaLase funding

How much has ViaLase raised?: ViaLase has raised $40M in total disclosed funding across the rounds on record.
Who has invested in ViaLase?: Venture Investors Health Fund, Arboretum Ventures, Falcon Vision, KKR are named among the investors backing ViaLase.
What was the latest ViaLase funding round?: The most recent disclosed round is a Series C, announced in April 2024.
Where is ViaLase based?: ViaLase is based in Irvine, California.
When did ViaLase last raise?: The last disclosed ViaLase round closed in April 2024 at Series C.

ViaLase totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Irvine below to benchmark round size and investor mix.

ViaLase Funding: $40M Raised, Series C (2024)

ViaLase funding overview

ViaLase at a glance

Frequently asked about ViaLase funding

Companies related to ViaLase (21)

Browse related funding lists (5)